TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
WALTHAM, Mass., Aug. 23, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in four upcoming investor conferences. The four conferences are:
- The Wells Fargo Global Healthcare Conference at the Westin Boston Waterfront in Boston on Wednesday, September 6. Tim Pearson, Executive Vice President and CFO of TESARO, is scheduled to present an overview of the Company’s business and development programs at 9:40 AM ET on September 6, and will also host meetings with investors.
- The 12th Annual Citi Biotech Day at the Mandarin Oriental Hotel in Boston on Wednesday, September 6 and Thursday, September 7, 2017. Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, are scheduled to participate in an analyst-led fireside chat from 10:00 to 10:50 AM ET on Thursday, September 7, and will also host meetings with investors.
- The Baird 2017 Global Healthcare Conference at the InterContinental New York Barclay in New York City on Wednesday, September 6. Grant Bogle, Senior Vice President and Chief Commercial Officer of TESARO, is scheduled to participate in an analyst-led fireside chat from 9:40 to 10:10 AM ET on September 6, and will also host meetings with investors.
- The Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology at the Lotte New York Palace in New York City on Thursday, September 28, 2017. Lonnie Moulder and Mary Lynne Hedley, Ph.D. will participate in an analyst-led fireside chat from 1:00 to 1:55 PM ET, and in meetings with investors.
Live webcasts of the presentations at the Wells Fargo, Citi, Baird and Leerink Partners conferences will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company’s website for 14 days following the conferences.
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
For additional information, please contact: Jennifer Davis 1.781.325.1116 [email protected]
